NCT04294043View on ClinicalTrials.gov

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Nontuberculous Mycobacterium Infection
Interventions
DRUG

Gallium nitrate

Study subjects will receive an infusion of gallium nitrate.

Trial Locations (10)

15224

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

21205

RECRUITING

Johns Hopkins University, Baltimore

29425

RECRUITING

Medical University of South Carolina, Charleston

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

43205

RECRUITING

Nationwide Children's Hospital, Columbus

55455

RECRUITING

The Minnesota Cystic Fibrosis Center, Minneapolis

75390

RECRUITING

University of Texas Southwestern, Dallas

80206

RECRUITING

National Jewish Health, Denver

98195

RECRUITING

University of Washington Medical Center, Seattle

05401

RECRUITING

University of Vermont Medical Center, Burlington

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Chris Goss

OTHER